These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24434435)

  • 41. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
    Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
    Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
    Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J
    Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
    Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
    Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites.
    Han S; Roman J
    Int J Cancer; 2005 Sep; 116(4):536-46. PubMed ID: 15825163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.
    Shi L; Zhang B; Sun X; Lu S; Liu Z; Liu Y; Li H; Wang L; Wang X; Zhao C
    Br J Cancer; 2014 Dec; 111(12):2316-27. PubMed ID: 25412236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.
    Yan A; Yang C; Chen Z; Li C; Cai L
    Cell Physiol Biochem; 2015; 37(1):55-66. PubMed ID: 26278569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI.
    Luo X; Zhang X; Peng J; Chen Y; Zhao W; Jiang X; Su L; Xie M; Lin B
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33103723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.